SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb

RRID Number: AB_2827974
COVID-19 Nucleocapsid Research.
1/1
Price:
Size:
Number:

SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb の製品情報

製品名
SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb
検証済のアプリケーション
WB,ELISA
アプリケーションの説明
IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
特異性
SARS Coronavirus Nucleocapsid
Has cross-reactivity in ELISA and WB with
SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Cat# 40588-V08B)
No cross-reactivity in ELISA with
MERS-CoV Nucleoprotein protein (40068-V08B)
HCoV-229E Nucleoprotein protein (40640-V07E)
HCoV-NL63 Nucleoprotein protein (40641-V07E)
HCoV-HKU1(isolate N5) Nucleoprotein protein (40642-V07E)
HCoV-OC43 Nucleoprotein (40643-V07E)
免疫原
Recombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
調製
This product is a recombinant monoclonal antibody expressed from HEK293 cells.
ソース
Monoclonal Rabbit IgG Clone #001
精製
Protein A
緩衝液
0.2 μm filtered solution in PBS
標識物
Unconjugated
状態
Liquid
配送方法
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
保存条件
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb 検証済のアプリケーション

アプリケーション 推奨希釈率/用量
WB 1:1000-1:5000
ELISA 1:5000-1:10000
Please Note: Optimal concentrations/dilutions should be determined by the end user.

SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb の画像

Anti-SARS-NP rabbit monoclonal antibody at 1:2000 dilution.

Lane A: SARS-CoV NP Protein (Cat#40143-V08B) (30ng)

Lane B: SARS-CoV NP Protein (Cat#40143-V08B) (5ng)

Lane C: SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B) (30ng)

Lane D: SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B) (5ng)

Secondary

Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb: 別名

Anti-coronavirus NP Antibody; Anti-coronavirus Nucleocapsid Antibody; Anti-coronavirus Nucleoprotein Antibody; Anti-cov np Antibody; Anti-ncov NP Antibody; Anti-novel coronavirus NP Antibody; Anti-novel coronavirus Nucleocapsid Antibody; Anti-novel coronavirus Nucleoprotein Antibody; Anti-NP Antibody; Anti-Nucleocapsid Antibody; Anti-Nucleoprotein Antibody

Coronavirus Nucleocapsid 背景情報

Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
参考文献
    1. 1.Van Boheemen S, et al. (2012), MBio. 3(6):e00473-12.
    2. Bisht H. et al., 2004, Proc Natl Acad Sci. 101 (17): 6641-6.
    3. Li W. et al., 2005, Science. 309 (5742): 1864-8.
  • Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
    Author
    Diao, B;Feng, Z;Wang, C;Wang, H;Liu, L;Wang, C;
    Year
    2020
    Journal
    medRxiv
    Application
    IHC
  • Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
    Author
    Jeon, S;Ko, M;Lee, J;Choi, I;Byun, SY;Park, S;Shum, D;
    Year
    2020
    Journal
    bioRxiv
  • Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA.
    Author
    Rosendal, E;Wigren, J;Groening, R;Yongdae, K;Nilsson, E;Sharma, A;espaillat, a;Hanke, L;Thunberg, T;McInerney, G;Puhar, A;Cava, F;Karlsson Hedestam, G;Monsen, T;Elgh, F;Blomkvist, B;Marklund, I;Ahlm, C;Evander, M;Normark, J;Johansson, A;Overby, A;Forsell, M;
    Year
    2020
    Journal
    medRxiv
    Application
    Fluorescent inhibition assay
  • Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma
    Author
    Salazar, E;Kuchipudi, SV;Christensen, PA;Eagar, TN;Yi, X;Zhao, P;Jin, Z;Long, SW;Olsen, RJ;Chen, J;Castillo, B;Leveque, C;Towers, DM;Lavinder, J;Gollihar, JD;Cardona, J;Ippolito, GC;Nissly, RH;Bird, IM;Greenawalt, D;Rossi, RM;Gontu, A;Srinivasan, S;Poojary, IB;Cattadori, IM;Hudson, PJ;Joselyn, N;Prugar, L;Huie, K;Herbert, A;Bernard, DW;Dye, J;Kapur, V;Musser, JM;
    Year
    2020
    Journal
    bioRxiv
    Application
    Microneutralization Assay

Standard Antibody Development Service

Rabbit MAb

Mouse MAb

Rabbit PAb

Fast Antibody Development Service

Mouse MAb

Rabbit PAb

カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください U.S.A.